Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S4W-13388 · Session 4

Whether it can confirm that the drug, ipilimumab, has been made available to patients with metastatic malignant melanoma in every country t…

Answered Asked by Ken Macintosh Lab Lodged 28 Feb 2013

The question

To ask the Scottish Government whether it can confirm that the drug, ipilimumab, has been made available to patients with metastatic malignant melanoma in every country that has completed its regulatory review of the new treatment.

The answer

Answered by Alex Neil on 12 Mar 2013 · 12 days after it was lodged, on time

The Scottish Government does not hold information about which medicines are made available to patients with a particular condition, including metastatic malignant melanoma, in other countries. National advice from each UK country on ipilimumab is published on their respective websites.

In the Official Report

No contribution in the Official Report cites S4W-13388 by reference.